STOCK TITAN

[Form 4] Cadre Holdings, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Cadre Holdings (CDRE) filed a Form 4 showing an officer sale. On 10/14/2025, the company’s President sold 4,132 shares of Common Stock at $40 per share, coded “S.” The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 14, 2025. Following the sale, the officer beneficially owns 110,221 shares directly.

Cadre Holdings (CDRE) ha depositato un Modulo Form 4 che mostra una vendita da parte di un dirigente. Il 14/10/2025, il presidente della società ha venduto 4.132 azioni di azioni ordinarie a 40 dollari per azione, codificate come «S». La transazione è stata effettuata ai sensi di un piano di trading 10b5-1 adottato il 14 maggio 2025. Dopo la vendita, l'ufficiale detiene direttamente 110.221 azioni.

Cadre Holdings (CDRE) presentó un Formulario 4 que muestra una venta por parte de un directivo. El 14/10/2025, el presidente de la empresa vendió 4.132 acciones ordinarias a 40 dólares por acción, codificadas como 'S'. La operación se realizó conforme a un plan de trading Rule 10b5-1 adoptado el 14 de mayo de 2025. Tras la venta, el directivo posee directamente 110.221 acciones.

Cadre Holdings (CDRE)는 임원 매출을 보여주는 Form 4를 제출했습니다. 2025년 10월 14일, 회사의 사장이 보통주를 주당 40달러에 4,132주를 매도했고, 거래 코드는 'S'로 표기되었습니다. 이 거래는 2025년 5월 14일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다. 매도 후, 그 임원은 직접 110,221주를 보유합니다.

Cadre Holdings (CDRE) a soumis un formulaire Form 4 indiquant une vente par un dirigeant. Le 14/10/2025, le président de la société a vendu 4 132 actions ordinaires à 40 dollars par action, codées « S ». La transaction a été réalisée conformément à un plan de trading Rule 10b5-1 adopté le 14 mai 2025. Suite à la vente, le dirigeant détient directement 110 221 actions.

Cadre Holdings (CDRE) hat ein Form 4 eingereicht, das einen Verkauf durch ein Vorstandsmitglied zeigt. Am 14.10.2025 verkaufte der Präsident des Unternehmens 4.132 Stammaktien zu 40 USD pro Aktie, kodiert mit „S“. Die Transaktion erfolgte gemäß einem am 14. Mai 2025 angenommenen Handelsplan nach Rule 10b5-1. Nach dem Verkauf besitzt das Vorstandsmitglied direkt 110.221 Aktien.

قدمت Cadre Holdings (CDRE) نموذج Form 4 يُظهر بيعًا من قبل موظف تنفيذي. في 14/10/2025 باع رئيس الشركة 4,132 سهمًا من الأسهم العادية بسعر 40 دولارًا للسهم، رمزها «S». تمت الصفقة وفقًا لخطة تداول Rule 10b5-1 التي اعتمدت في 14 مايو 2025. بعد البيع، يمتلك الموظف التنفيذي 110,221 سهمًا مباشرة.

Cadre Holdings (CDRE) 已提交 Form 4,显示为一位高管的出售。 2025年10月14日,公司的总裁以每股40美元出售了4,132股普通股,交易代码为“S”。该交易依据于于2025年5月14日通过的 Rule 10b5-1 交易计划执行。出售后,该高管直接持有110,221股。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Cadre Holdings (CDRE) ha depositato un Modulo Form 4 che mostra una vendita da parte di un dirigente. Il 14/10/2025, il presidente della società ha venduto 4.132 azioni di azioni ordinarie a 40 dollari per azione, codificate come «S». La transazione è stata effettuata ai sensi di un piano di trading 10b5-1 adottato il 14 maggio 2025. Dopo la vendita, l'ufficiale detiene direttamente 110.221 azioni.

Cadre Holdings (CDRE) presentó un Formulario 4 que muestra una venta por parte de un directivo. El 14/10/2025, el presidente de la empresa vendió 4.132 acciones ordinarias a 40 dólares por acción, codificadas como 'S'. La operación se realizó conforme a un plan de trading Rule 10b5-1 adoptado el 14 de mayo de 2025. Tras la venta, el directivo posee directamente 110.221 acciones.

Cadre Holdings (CDRE)는 임원 매출을 보여주는 Form 4를 제출했습니다. 2025년 10월 14일, 회사의 사장이 보통주를 주당 40달러에 4,132주를 매도했고, 거래 코드는 'S'로 표기되었습니다. 이 거래는 2025년 5월 14일에 채택된 Rule 10b5-1 거래 계획에 따라 실행되었습니다. 매도 후, 그 임원은 직접 110,221주를 보유합니다.

Cadre Holdings (CDRE) a soumis un formulaire Form 4 indiquant une vente par un dirigeant. Le 14/10/2025, le président de la société a vendu 4 132 actions ordinaires à 40 dollars par action, codées « S ». La transaction a été réalisée conformément à un plan de trading Rule 10b5-1 adopté le 14 mai 2025. Suite à la vente, le dirigeant détient directement 110 221 actions.

Cadre Holdings (CDRE) hat ein Form 4 eingereicht, das einen Verkauf durch ein Vorstandsmitglied zeigt. Am 14.10.2025 verkaufte der Präsident des Unternehmens 4.132 Stammaktien zu 40 USD pro Aktie, kodiert mit „S“. Die Transaktion erfolgte gemäß einem am 14. Mai 2025 angenommenen Handelsplan nach Rule 10b5-1. Nach dem Verkauf besitzt das Vorstandsmitglied direkt 110.221 Aktien.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Williams Brad

(Last) (First) (Middle)
C/O CADRE HOLDINGS, INC.
13386 INTERNATIONAL PKWY

(Street)
JACKSONVILLE FL 32218

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PRESIDENT
3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share ("Common Stock") 10/14/2025 S(1) 4,132 D $40 110,221 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.
/s/ Brad Williams 10/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Cadre Hldgs Inc

NYSE:CDRE

CDRE Rankings

CDRE Latest News

CDRE Latest SEC Filings

CDRE Stock Data

1.67B
28.83M
29.12%
69.63%
4.85%
Aerospace & Defense
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
JACKSONVILLE